Telemetry Investments, L.L.C. Matinas Bio Pharma Holdings, Inc. Transaction History

Telemetry Investments, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$0.63 - $2.27 $271,872 - $979,604	-431,544 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$0.59 - $0.9 $84,414 - $128,767	-143,075 Reduced 24.9%	431,544 $272,000
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.11 $59,550 - $83,672	-75,381 Reduced 11.6%	574,619 $492,000
Q1 2019 May 15, 2019	BUY	$0.6 - $1.41 $390,000 - $916,500	650,000 New	650,000 $708,000

3.66M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $137M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.